US 9675684
Gene optimized hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndrome
granted A61KA61K2039/53A61K2039/575
Quick answer
US patent 9675684 (Gene optimized hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndrome) held by The United States of America as represented by the Secretary of the Army expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/53, A61K2039/575, A61K2039/70, A61K39/12